Our Team



1 2 > >>

Martin Godbout


Martin Godbout, O.C., PhD

Chair of the Board


Following a brief academic career at Université Laval in the early 90s, Martin Godbout was named President and General Manager of Société Innovatech Québec. In 1997, he pursued his career in the biopharmaceutical venture capital sector as Senior Vice President of BioCapital. In May 2000, he became the founding President and CEO of Genome Canada, which he led for nearly 10 years.

 

Officer of the Order of Canada, Mr. Godbout is currently Chair of the Board of AmorChem-1, BioContact, BIOQuebec and Genome Quebec. He is also an independent Board member of the following organizations: AngioChem, Fonds de recherche du Québec - Santé, P3G, Ataxia Charlevoix-Saguenay Fondation, Leucodystrophies Fondation and Baie-Saint-Paul Hospital Fondation.

 

Mr. Godbout holds a PhD in Physiology and Molecular Endocrinology from Université Laval and completed a postdoctoral training in neuromolecular biology at the Scripps Research Institute, in San Diego. In 2016, he was named Grand Diplômé from Université Laval.


Marie-Josée Blais


Marie-Josée Blais, PhD

Observer


Assistant Deputy Minister, ministère de l'Économie, de la Science et de l'Innovation


Isabelle Bouffard


Isabelle Bouffard, BSc


Director, Direction recherches et politiques agricoles
Union des producteurs agricoles


Isabelle Bouffard holds a Bachelor of Agricultural Economics from McGill University. Since 2005, she has worked for the Research and Agricultural Policy department of the Union des producteurs agricoles (UPA). In 2016, she was appointed director of the department.

 

Prior to this, she worked as economic advisor and subsequently as manager of the economics and commerce team. Over the years, she has coordinated efforts in a variety of areas, including commerce, economics, energy and municipal taxation pertaining to agriculture. In this capacity, she has participated in the work of many provincial and national committees.


Alain Bourque


Alain Bourque, MSc


Executive Director, Ouranos


Alain Bourque holds a Master's in atmospheric science from Université du Québec à Montréal (UQÀM). He was a meteorologist/climatologist with Environment and Climate Change Canada from 1989 to 2001 where he worked on the Saguenay flood of 1996, the ice storm of 1998 and with climate services. At Ouranos since its creation in 2001, Mr. Bourque has implemented the Vulnerabilities, Impacts and Adaptation program which includes more than 200 projects. Since 2013, he serves as Executive Director. During his career, he has completed many regional, national and international scientific summaries and contributes regularly to media stories and policy discussions about climate change and adaptation.


Me Jean Brunet


Me Jean Brunet

Secretary of the Board


Managing Partner of Stein Monast L.L.P.

 

Jean Brunet specializes in corporate and commercial law, including the negotiation and drafting of business purchase and sales agreements, mergers, corporate reorganizations and shareholders’ agreements. Mr. Brunet also practises intellectual property law, including negotiating and drafting research contracts, distribution agreements, and licence and technology transfer agreements, mainly in the sectors of pharmaceuticals, genomics, proteomics, bioinformatics and biotechnology.

 

In addition, Mr. Brunet acts as legal counsel and corporate secretary for various companies, particularly in the areas of biotechnology, genomics and proteomics, including active involvement on the boards of Genome Canada and Génome Québec. His duties include advising these companies on corporate governance policies and compliance matters. Mr. Brunet is one of the founders and directors of BioContact, an annual biotechnology symposium.


Daniel Coderre


Daniel Coderre, PhD

President and CEO, Génome Québec


Since September 2016, Daniel Coderre is President and CEO of Génome Québec, an organization supporting scientific and strategic development of genomics in Québec.


A certified corporate director (ASC - Administrateur de sociétés certifié) Mr. Coderre has a proven track record in public administration.
 

Daniel Coderre served as Rector of the Institut national de la recherche scientifique (INRS) from 2009 to 2016, where he acquired solid expertise in public administration and built a wide network of partners.

He holds a doctorate in biology from the Université de Sherbrooke. He began his career in 1982 as a biology professor at UQAM, where he supervised 85 masters and doctoral students and published nearly 100 scientific publications. He also served as Dean of the Faculty of Science and Vice-Rector of Research before being appointed Vice-President of Academic Affairs and Research from 2004 to 2009 and in 2009, as its Interim President.

He has held positions on close to twenty committees, boards of directors, scientific, government and international committees and various commissions on science, technology and innovation.


Hélène Desmarais


Hélène Desmarais, C.M., LL.D.


CEO and Chair of the Board of Administration, Centre d'entreprises et d'innovation de Montréal

 

Founder, CEO and Chair of the Board of Administration of the Centre d'entreprises et d'innovation de Montréal (CEIM) since 1996, Ms. Hélène Desmarais holds a Bachelor of Business Administration in finance from HEC Montréal. CEIM is a business incubator, with an emphasis on startups as well as the development of innovative IT, multimedia, industrial technology and biotech companies. CEIM supports the emergence of viable, innovative and successful companies from those sectors which are an economic priority for the Greater Metropolitan Area of Montréal and the province of Québec.

 

 Ms. Desmarais is founder and Chair of the Board of Administration and of the Entrepreneurial Development Committee of the Société de développement économique Ville-Marie (SDEVM) since 1998. She is both Chair of the Board of Administration and of the Financial Assistance Committee of the SDEVM's Société d'Investissement Jeunesse (SIJ) Loan Guarantee Program. The primary mission of these two organisations is to promote entrepreneurship and economic development. The SDEVM primarily offers commercial loan guarantees to startup companies. The SIJ offers personal loan guarantees to young entrepreneurs under 35, who wish to start, acquire or become an associate in a Québec business.

 

Gestion Bio-Capital Inc. was founded in 1997 and was led by Ms. Desmarais as Chair of the Board of Administration until the sale of the fund in 2001. She was also a member of the verification and investment committees and member of the private investment evaluation committee at the time of the sale of the fund. Gestion Bio-Capital Inc. was a venture capital organisation specializing in biotech startups.

 

In 2003, Ms. Desmarais was appointed first female President of HEC's Board of Administration, to which she had been named in 1999. She is Co-President and founder of the International Advisory Board of HEC Montréal (1990), is chair of the University of Montreal's Faculty of Medicine Advisory Committee (2006), is chair of the advisory board of the Consultative Committee of the Hospital Centre of the Université de Montréal (CHUM) (2008), is President of the Advisory Board and member of the Board of Governors of the Conference of Montreal (International Economic Forum of the Americas, 1995), is President of the Board of Administration of The Montreal Economic Institute (2007) where she has held a seat since 2002, is Chair of the Canadian Joint Regional Committees since 2006, was President of the Board of Directors of the Board of Trade of Metropolitan Montreal. She was on the Board of Trade of Metropolitan Montreal from 2002-2009 and has sat on its Executive Committee since 2005. She has been Deputy Chair of the Montreal Symphony Orchestra and Chair and founder of its Fondation since 2008.  She chaired a commission formed by the Province of Quebec to study the healthcare industry (1997). 

 

Ms. Desmarais also sits on the following Boards of administrations : Garda World Security Corporation (2006); C.D. Howe Institute (2005); the Institute for Governance of Private and Public Organizations (2005); of the IRCM - The Institut de recherches cliniques de Montréal (2005), of Génome Québec (2002), of VAL-CHUM -- Société de valorisation des recherches du CHUM (2004). She is a member of the Conseil des partenaires de l'innovation (CIP), which falls under the aegis of Quebec's Ministry of Développement économique, Innovation et Exportation (2006), of the City of Montreal Economic Orientation Committee (2005), of the advisory board of Biotechnology Research Iinstitute, National Research Council of Canada (1998-2001) and of the Investment Committee, Hydro-Quebec CapiTech - Innovation Fund (2001-2004).

 

Recipient, Queen Elizabeth II’s Golden Jubilee Medal 2002; Order of Merit, Université de Montréal 2007; Medal of Honour, Faculty of Medicine of the Université de Montréal 2009; Doctor of Laws honoris causa, St. Francis Xavier University 2009; Order of Canada, Chancellery of Honours 2009; Prix entrepreneurship of Conseil du Patronat du Québec 2010; Grande Montréalaise (economic sector), Académie des grands montréalais and la Chambre de commerce du Montréal métropolitain 2010. 


Jean-François Ethier


Jean-François Ethier

MD, CM, PhD, FRCPC


Clinical Researcher and Assistant Professor
Department of medicine, Université de Sherbrooke


Professor Jean-François Ethier is a clinical researcher and assistant professor at the Department of Medicine of Université de Sherbrooke. He also works as a researcher at the INSERM UMRS-1138 in Paris in addition to coleading the Groupe de recherche interdisciplinaire en informatique de la santé (GRIIS.ca).


He holds a Bachelor of Internal Medicine from McGill University and a PhD in Epidemiology and Biomedical Information Science from Université Paris VI (Pierre and Marie Curie).


Pr. Ethier’s research focuses on ways to place patients at the centre of research and decision support systems (learning healthcare system). More specifically, he develops semantic interoperability frameworks between health and research systems, structures biomedical data warehouses and develops formal knowledge-based models to facilitate the uniform access to clinical, genomics, administrative and quantified self (lifelogging) data. 


David Jarry


David Jarry, MSc, LL.M.


Partner, MNP

 

Mr. David Jarry is a Partner and Business Advisor with MNP and provides a full range of accounting, tax and business consulting services for clients in the public, private and not-for-profit sectors.


Mr. Jarry has served clients across a wide range of industries, dealing with every region of the world and more than 50 countries. He has extensive experience in international business growth optimization taking into consideration innovation, operation, human resources, technology, and financial parameters, from small to large companies.


Mr. Jarry has expertise in the service areas of international tax, project valuations, mergers and acquisitions, business plans, expansion plans, governance, strategic planning, organizational evaluation, performance measurement and organizational improvement.


Mr. Jarry has extensive experience working in consultation working with a Big Four public accounting firm in Canada and in Europe. He also has experience in the industry working for an international public company in the life sciences industry.


In addition to his role as the Leader of the Montreal International Tax Practice, Mr. Jarry is a member of MNP’s Tax Executive Committee. He is also the Vice-Chair of the North America Tax & Fiscal Group, as well as being an advisor to the Strategy Committee for Global Tax Group, for the Praxity Alliance.


Mr. Jarry has a Bachelor (BSc) and a Master of Science (MSc) degree in economics from the Université de Montréal and a Master of Laws (LL.M.) degree from Maastricht University.


Marc LePage


Marc LePage

Observer


President and CEO, Genome Canada

 

Marc LePage was appointed President and CEO of Genome Canada December 2015. Before this, he served as President and CEO of Génome Québec since December 2011, where he led a major increase in research activity and enhanced focus on the development of genomic applications within priority sectors within the province.  


He brings a wealth of experience in the innovation sector and venture capital, in addition to a broad network of international contacts.


He is an expert in international partnerships and previously served as Special Advisor, Climate Change and Energy for the Embassy of Canada in Washington, D.C. and worked as Consul General at the Canadian Consulate in San Francisco/Silicon Valley.


Marc LePage was also one of the pioneers behind the founding of Genome Canada in 2000. During his tenure as Executive Vice-President of Corporate Development, he made a significant contribution to the development of genomics in Canada.


From 1994 to 2000, he worked as Director of Business Development for the Medical Research Council, where he was in charge of building international partnerships with the pharmaceutical industry, venture capital and foundations.


Marc LePage is a member of the Board and the Governance Committee of the Quebec Network for Personalized Health Care. He also sits on the Board of Canada World Youth.


1 2 > >>